Viewing Study NCT05053750


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-02-07 @ 2:32 PM
Study NCT ID: NCT05053750
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-14
First Post: 2021-09-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epithelial Ovarian View
None Fallopian Tube View
None Primary Peritoneal Cancer View
Keywords: